Latest Breaking News On - Novartis prevailed - Page 1 : comparemela.com

Novartis Pharms. Corp. v. Mylan Pharms. Inc. - Entresto® (Sacubitril/Valsartan) | Robins Kaplan LLP

Case Name: Novartis Pharms. Corp. v. Mylan Pharms. Inc., Civ. No. 19-cv-201, 2024 WL 384929 (N.D.W.V. Jan. 31, 2024) (Kleeh, J.) - Drug Product and Patent(s)-in-Suit: Entresto®.

Novartis Pharms. Corp. v. Mylan Pharms. Inc. - Entresto® (Sacubitril / Valsartan) | Robins Kaplan LLP

Case Name: Novartis Pharms. Corp. v. Mylan Pharms. Inc., Civ. No. 19-cv-201, 2023 WL 4375445 (N.D.W.V. July 6, 2023) (Kleeh, J.) - Drug Product and Patent(s)-in-Suit: Entresto®.

Novartis Pharms. Corp. v. Alembic Pharms. Ltd. - Entresto® (Sacubitril/Valsartan) | Robins Kaplan LLP

Case Name: Novartis Pharms. Corp. v. Alembic Pharms. Ltd., Civ. No. 22-1395-RGA, 2023 WL 6387975 (D. Del. Sept. 29, 2023) (Andrews, J.). Drug Product and Patent(s)-in-Suit: Entresto®.

Novartis Pharms. Corp. v. Accord Healthcare, Inc. | Robins Kaplan LLP